PulseAugur
EN
LIVE 00:34:16
中文(ZH) 菜百股份：明牌实业提前终止减持计划，实际未减持股份

Mingpai Industrial halts Caibai stake reduction; Rejebio drug trial expands

By PulseAugur Editorial · [1 sources] ·

Zhejiang Mingpai Industrial Co., Ltd. has decided to terminate its plan to reduce its stake in Caibai Co., Ltd., having not sold any shares. Concurrently, Shun Jing Pharmaceutical, a subsidiary of Rejebio, has received approval from China's National Medical Products Administration for a clinical trial of its innovative drug SGC001 injection. This drug, previously approved by the FDA and CDE for acute myocardial infarction treatment, will now also be investigated for severe acute pancreatitis. AI

RANK_REASON The cluster contains multiple unrelated news items, including a shareholder's decision to terminate a stake reduction plan and a subsidiary's drug trial approval, presented in a digest format.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Mingpai Industrial halts Caibai stake reduction; Rejebio drug trial expands

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Commentary
The cluster contains multiple unrelated news items, including a shareholder's decision to terminate a stake reduction plan and a subsidiary's drug trial approval, presented in a digest format.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
124 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Caibai Stock: Mingpai Industrial terminates share reduction plan early, no shares actually reduced

    36氪获悉，菜百股份公告，公司持股16.2%的股东浙江明牌实业股份有限公司（简称“明牌实业”）基于自身资金需求的变化及对公司价值的判断，决定提前终止减持股份计划；此次减持计划实施期间，明牌实业合计减持所持公司股份0股。

RELATED ENTITIES

RELATED TOPICS